Op-ed: Long-term care pharmacies matter to rural Idaho
By Ashley Brittain | Published November 19, 2025 in Idaho Mountain Express
Access to health care in rural Idaho is critical, which is why I’m concerned about a serious problem facing our long-term care communities. Because of changes in drug pricing, as of Jan. 1, we may see 60% of America’s long-term care pharmacies close.
Long-term care pharmacies provide specialized services that federal law requires for nursing home and assisted living residents. In rural Idaho, there are 71,844 Medicare beneficiaries, and just four LTC pharmacies operate in rural communities. When you’re dealing with distances measured in dozens of miles and limited alternatives, losing even one pharmacy can leave hundreds of seniors without access to medications and required services.
Congressional bill H.R. 5031, also known as the Preserving Patient Access to Long-Term Care Pharmacies Act, provides a reasonable solution. It establishes a $30 supplemental supply fee for the drugs subject to negotiated prices in 2026 and 2027, covering the cost of the specialized services these pharmacies must provide. It also directs the U.S. Government of Accountability Office to develop a permanent, sustainable reimbursement structure. This approach is modeled after Medicare Part B legislation Congress passed in 2003, and it has broad bipartisan support from organizations across the long-term care sector.
The Trump administration can also explore administrative solutions, such as a Centers for Medicare & Medicaid Services (CMS) waiver or other regulatory fixes that could provide relief while Congress works on permanent legislation.
I urge our Idaho congressional delegation and the Trump administration to work quickly and urgently. Rural communities can’t afford to lose these services, and our seniors shouldn’t have to pay the price for a well-intentioned policy that didn’t account for their needs.
Read the full article on Idaho Mountain Express here
Recent Posts
-
Senior Care Pharmacy Coalition Releases Statement in Support of the PBM Price Transparency and Accountability Act
SCPC commends Senators Mike Crapo (R-ID) and Ron Wyden (D-OR) for championing federal PBM reform through bipartisan legislation that targets the predatory practices of pharmacy benefit managers. These abuses continue to harm patients across the nation, particularly America’s seniors and the LTC pharmacies dedicated to serving them.
-
Op-ed: Trump Administration must act to preserve senior care
During my years representing the rural communities of southcentral
Pennsylvania, I learned that when a system works smoothly and
efficiently, people take it for granted. -
Medicare Part D 2027 MFP Drugs Underscores the Urgent Need for Congress to Pass H.R. 5031 / S. 3159
The Senior Care Pharmacy Coalition (SCPC), the leading voice for the nation’s long-term care (LTC) pharmacy community, released the following statement regarding the pricing announcement of 2027 MFP drugs under the Medicare Part D drug price negotiation program. “The Centers for Medicaid and Medicare Services’ (CMS) announcement of the negotiated prices for the 2027 Medicare […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.